Sensus Healthcare, Inc. is a medical device company that is engaged in the development and delivery of non-invasive treatments for skin cancer and keloids. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.
公司代码SRTS
公司名称Sensus Healthcare Inc
上市日期Jun 03, 2016
CEOSardano (Joseph C)
员工数量35
证券类型Ordinary Share
年结日Jun 03
公司地址851 Broken Sound Pkwy NW Ste 215
城市BOCA RATON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编33487-3635
电话15619225808
网址https://sensushealthcare.com/
公司代码SRTS
上市日期Jun 03, 2016
CEOSardano (Joseph C)